Tumour necrosis factor (TNF)α −308 G/G promoter polymorphism and TNFα levels correlate with a better response to adalimumab in patients with rheumatoid arthritis
Cuchacovich, M., Soto, L., Edwardes, M., Gutierrez, M., Llanos, C., Pacheco, D., Sabugo, F., Alamo, M., Fuentealba, C., Villanueva, L., Gatica, H., Schiattino, I., Salazar, L., Catalan, D., ValenzuelaVolume:
35
Language:
english
Journal:
Scandinavian Journal of Rheumatology
DOI:
10.1080/03009740600904284
Date:
January, 2006
File:
PDF, 284 KB
english, 2006